A User's Guide to the Interactive Web Database of Factor H-Associated Hemolytic Uremic Syndrome

ABSTRACT

Atypical hemolytic uremic syndrome (aHUS) mutations have been reported in the complement regulatory proteins factor H, factor I, and membrane cofactor protein (MCP). Mutations within factor H are also associated with membranoproliferative glomerulonephritis and age-related macular degeneration. The increasing amount of information on aHUS requires organization if it is to be usable. Accordingly, an interactive factor H aHUS Web database has been developed (http://www.fh-hus.org) that integrates genotypic, phenotypic, and structural information for mutations within human factor H. This provides a valuable tool for the interpretation of previously reported aHUS mutations, and provides prediction and analysis tools for new mutations. It will be extended to include mutations in factor I and MCP. Here, we describe how to use this Web database as a research tool, and indicate possible future directions depending on feedback from the clinical community.

Factor H - hemolytic uremic syndrome - mutation - factor I - membrane cofactor protein

REFERENCES

• 1 Perkins S J, Goodship T HJ. Molecular modelling of mutations in the C-terminal domains of factor H of human complement: a new insight into haemolytic uraemic syndrome.  J Mol Biol. 2002;  316 217-224
• 2 Warwicker P, Goodship T HJ, Donne R L et al.. Genetic studies into inherited and sporadic haemolytic uraemic syndrome.  Kidney Int. 1998;  53 836-844
• 3 Buddles M R, Donne R L, Richards A, Goodship J A, Goodship T HJ. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.  Am J Hum Genet. 2000;  66 1721-1722
• 4 Sanchez-Corral P, Bellavia D, Amico L, Brai M, Rodriguez de Cordoba S. Molecular basis for factor H and FHL-1 deficiency in an Italian family.  Immunogenetics. 2000;  51 366-369
• 5 Richards A, Buddles M R, Donne R L et al.. Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.  Am J Hum Genet. 2001;  68 485-490
• 6 Pérez-Caballero D, González-Rubio C, Gallardo M E, Vera M, López-Trascasa M, Rodríguez de Córdoba S. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.  Am J Hum Genet. 2001;  68 478-484
• 7 Caprioli J, Bettinaglio P, Zipfel P F et al.. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.  J Am Soc Nephrol. 2001;  12 297-307
• 8 Remuzzi G, Ruggenenti P, Codazzi D et al.. Combined kidney and liver transplantation for familial haemolytic uraemic syndrome.  Lancet. 2002;  359 1671-1672
• 9 Sanchez-Corral P, Perez-Caballero D, Huarte O et al.. Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome.  Am J Hum Genet. 2002;  71 1285-1295
• 10 Caprioli J, Castelletti F, Bucchioni S et al.. International Registry of Recurrent and Familial HUS/TTP. 2003. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease.  Hum Mol Genet. 2003;  12 3385-3395
• 11 Manuelian T, Hellwage J, Meri S et al.. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.  J Clin Invest. 2003;  111 1181-1190
• 12 Neumann H P, Salzmann M, Bohnert-Iwan B et al.. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries.  J Med Genet. 2003;  40 676-681
• 13 Dragon-Durey M A, Fremeaux-Bacchi V, Loirat C et al.. Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases.  J Am Soc Nephrol. 2004;  15 787-795
• 14 Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations.  Mol Immunol. 2004;  41 355-367
• 15 Noris M, Brioschi S, Caprioli J et al.. Familial haemolytic uraemic syndrome and an MCP mutation.  Lancet. 2003;  362 1542-1547
• 16 Richards A, Kemp E J, Liszewski M K et al.. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.  Proc Natl Acad Sci U S A. 2003;  100 12966-12971
• 17 Fremeaux-Bacchi V, Dragon-Durey M A, Blouin J et al.. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome.  J Med Genet. 2004;  41 e84
• 18 Ballermann B J. Endothelial cell activation.  Kidney Int. 1998;  53 1810-1826
• 19 Saunders R E, Goodship T H, Zipfel P F, Perkins S J. An interactive web database of factor H associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.  Hum Mutat. 2005;  27 21-30
• 20 Ault B H, Schmidt B Z, Fowler N L et al.. Human factor H deficiency; mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism.  J Biol Chem. 1997;  272 25168-25175
• 21 Edwards A O, Ritter III R, Abel K J et al.. Complement factor H polymorphism and age-related macular degeneration.  Science. 2005;  308 421-424
• 22 Haines J L, Hauser M A, Schmidt S et al.. Complement factor H variant increases the risk of age-related macular degeneration.  Science. 2005;  308 419-421
• 23 Klein R J, Zeiss C, Chew E Y et al.. Complement factor H polymorphism in age-related macular degeneration.  Science. 2005;  308 385-389
• 24 Aslam M, Perkins S J. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling.  J Mol Biol. 2001;  309 1117-1138
• 25 Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.  Biopolymers. 1983;  22 2577-2637
• 26 Bordo D, Argos P. Suggestions for “safe” residue substitutions in site-directed mutagenesis.  J Mol Biol. 1991;  217 721-729
• 27 Berman H M, Westbrook J, Feng Z et al.. The Protein Data Bank.  Nucleic Acids Res. 2000;  28 235-242